Document Detail


Genaissance pharmaceuticals, inc.
MedLine Citation:
PMID:  11972448     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Genaissance Pharmaceuticals, Inc. (Nasdaq: GNSC) is the world leader in the discovery and use of gene variation for the development of personalized medicines. In addition, the company has established partnerships with some of the world's top biopharmaceutical companies. The company has initiated the development of its own pipeline of products -- HAP Clozapine for schizophrenia and HAP Statin for cholesterol management -- utilizing its proprietary genetic markers. The company also markets its technology and clinical development skills to the pharmaceutical industry as a complete solution for improving the development, marketing and prescribing of drugs.
Authors:
Paul Oestreicher
Related Documents :
12002588 - Treatment of canine aural hematoma with an indwelling drain.
8001948 - Setting up regional audit in genitourinary medicine and hiv: the south east thames expe...
20081588 - Specialty and curriculum development.
10112478 - Management development for primary health care: a framework for analysis.
4898388 - New prospects for the study of leprosy in the laboratory.
10176828 - Management education for undergraduate doctors. a survey of medical schools.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Pharmacogenomics     Volume:  3     ISSN:  1462-2416     ISO Abbreviation:  Pharmacogenomics     Publication Date:  2002 Mar 
Date Detail:
Created Date:  2002-04-25     Completed Date:  2002-08-23     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  100897350     Medline TA:  Pharmacogenomics     Country:  England    
Other Details:
Languages:  eng     Pagination:  273-6     Citation Subset:  IM    
Affiliation:
Strategic Marketing & Communications, Genaissance Pharmaceuticals Five Science Park, New Haven, CT 06511, USA. contact-us@genaissance.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cooperative Behavior
Drug Industry / methods*,  organization & administration,  trends
Genetic Variation / genetics
Humans

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Online genomics facilities in the new millennium.
Next Document:  Antizyme induction by polyamine analogues as a factor of cell growth inhibition.